|
1
|
Rüdiger T, Weisenburger DD, Anderson JR,
et al: Peripheral T-cell lymphoma (excluding anaplastic large cell
lymphoma): Results from the Non-Hodgkin’s Lymphoma Classification
Project. Ann Oncol. 13:140–149. 2002. View Article : Google Scholar
|
|
2
|
Bardwick PA, Zvaifler NJ, Gill GN, et al:
Plasma cell dyscrasia with polyneuropathy, organomegaly,
endocrinopathy, M protein, and skin changes: the POEMS syndrome.
Report on two cases and a review of the literature. Medicine
(Baltimore). 59:311–322. 1980. View Article : Google Scholar
|
|
3
|
Conable KM and Rosner AL: A narrative
review of manual muscle testing and implications for muscle testing
research. J Chiropr Med. 10:157–165. 2011.PubMed/NCBI
|
|
4
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H and Thiele J: World Health Organization
Classification of Tumors. Pathology and Genetics, Tumors of
Haematopoietic and Lymphoid Tissues. IARC Press; Washington, DC:
2008
|
|
5
|
Dispenzieri A, Kyle RA, Lacy MQ, et al:
POEMS syndrome: definitions and long-term outcome. Blood.
101:2496–2506. 2003. View Article : Google Scholar
|
|
6
|
Vokurka S, Koza V, Vozobulová V, et al:
Angioimmunoblastic T-cell lymphoma as a very poor-prognosis
malignancy - a single centre experience. Klin Onkol. 25:206–211.
2012.(In Czech).
|
|
7
|
Vose J, Armitage J, Weisenburger D, et al:
International T-Cell Lymphoma Project: International peripheral
T-cell and natural killer/T-cell lymphoma study: pathology findings
and clinical outcomes. J Clin Oncol. 26:4124–4130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mourad N, Mounier N, Brière J, et al:
Groupe d’Etude des Lymphomes de l’Adulte: Clinical, biologic, and
pathologic features in 157 patients with angioimmunoblastic T-cell
lymphoma treated within Groupe d’ Etude des-Lymphoms de l’Adulte
(GELA) trials. Blood. 111:4463–4470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abouyabis AN, Shenoy PJ, Sinha R, et al: A
systematie review and meta-analysis of front-line
anthracycline-based chemotherapy regimens for peripheral T-cell
lymphoma. ISRN Hematol. 2011:6239242011. View Article : Google Scholar
|
|
10
|
Schetelig J, Fetscher S, Reichle A, et al:
Long-term disease-free survival in patients with angioimmunoblastic
T-cell lymphoma after high-dose chemotherapy and autologous stem
cell transplantation. Haematologica. 88:1272–1278. 2003.PubMed/NCBI
|
|
11
|
Kyriakou C, Canals C, Sibon D, et al:
High-dose therapy and autologous stem-cell transplantation in
Waldenstrom macroglobulinemia: the Lymphoma Working Party of the
European Group for Blood and Marrow Transplantation. J Clin Oncol.
28:2227–2232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O’Connor OA, Pro B, Pinter-Brown L, et al:
Pralatrexate in patients with relapsed or refractory peripheral
T-cell lymphoma: result from the pivotal PROPEL study. J Clin
Oncol. 29:1182–1189. 2011. View Article : Google Scholar
|
|
13
|
Kim SJ, Yoon DH, Kang HJ, Kim JS, et al:
Bortezomib in combination with CHOP as first-line treatment for
patients with stage III/IV peripheral T-cell lymphomas: a
multicentre, single-arm, phase 2 trial. Eur J Cancer. 48:3223–3231.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fabbri A, Cencini E, Pietrini A, Gozzetti
A, et al: Impressive activity of lenalidomide monotherapy in
refractory angioimmunoblastic T-cell lymphoma: report of a case
with long-term follow-up. Hematol Oncol. 31:213–217. 2013.
View Article : Google Scholar
|
|
15
|
Mori M, Inoue D, Arima H, et al:
Therapeutic efficacy of cyclosporin A for refractory
angiommunoblastic T cell lymphoma. Rinsho Ketsueki. 51:332–338.
2010.(In Japanese). PubMed/NCBI
|
|
16
|
Kuan JW, Chang KM, Lau NS, et al: The
outcome of hyperCVAD combined with alemtuzumab for the treatment of
aggressive T-cell and NK-cell neoplasms. Indian J Hematol Blood
Transfus. 27:136–145. 2011. View Article : Google Scholar :
|
|
17
|
Gallamini A, Zaja F, Patti C, Billio A, et
al: Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line
treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo
Italiano Terapie Innovative nei Linfomi) prospective multicenter
trial. Blood. 110:2316–2323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aguiar Bujanda D: Complete response of
relapsed angioimmunoblastic T-cell lymphoma following therapy with
bevacizumab. Ann Oncol. 19:396–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mosalpuria K, Bociek RG and Vose JM:
Angioimmunoblastic T-cell lymphoma management. Semin Hematol.
51:52–58. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Viala K, Béhin A, Maisonobe T, et al:
Neuropathy in lymphoma: a relationship between the pattern of
neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg
Psychiatry. 79:778–782. 2008. View Article : Google Scholar
|
|
21
|
Nakayama S, Yokote T, Kobayashi K, et al:
Primary cutaneous diffuse large B-cell lymphoma, leg type, with
features simulating POEMS syndrome. Eur J Haematol. 84:79–83. 2010.
View Article : Google Scholar
|
|
22
|
Sasaki T, Onishi S, Onishi R, Takemura R,
et al: POEMS syndrome complicated by follicular lymphoma. Rinsho
Ketsueki. 50:1621–1625. 2009.PubMed/NCBI
|
|
23
|
Dupuis J, Boye K, Martin N, et al:
Expression of CXCL13 by neoplastic cells in angioimmunoblastic
T-cell lymphoma (AITL): a new diagnostic marker providing evidence
that AITL derives from follicular helper T-cells. Am J Surg Pathol.
30:490–494. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tachibana T, Tomita N, Furuya M, et al:
Aberrant CD20 expression in angioimmunoblastic T-cell lymphoma.
Intern Med. 50:495–499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iqbal J, Weisenburger DD, Greiner TC, et
al: Molecular signatures to improve diagnosis in peripheral T-cell
lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.
Blood. 115:1026–1036. 2010. View Article : Google Scholar :
|
|
26
|
Delfau-Larue MH, de Leval L, Joly B, et
al: Targeting intratumoral B cells with rituximab in addition to
CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological
study of the GELA. Haematologica. 97:1594–1602. 2012. View Article : Google Scholar : PubMed/NCBI
|
